Intracranial posterior fossa metastasis is a common entity. Metastatic mucinous adenocarcinoma presenting as cerebellopontine angle (CPA) tumor is very rare. The authors presented a 47-year-old female patient with right CPA tumor. The magnetic resonance imaging brain showed a heterogeneous contrast-enhancing dural-based extra-axial right CPA lesion involving the right cerebellar hemisphere, internal auditory meatus, and posterior surface of the right petrous bone. The patient underwent surgery, and subtotal resection of the tumor was done. Histology of the tumor was metastasis from a mucinous adenocarcinoma. Contrast-enhanced computed tomography scan of the abdomen and pelvis, ultrasound of the thyroid, chest X-ray, and thyroid function tests were normal. Carbohydrate antigen (CA) 19-9 was 949.37 U/mL, serum carcinoembryonic antigen (CEA) was 48.17 ng/mL, and CA-125 was 8.20 U/mL. In view of the raised CA 19-9 and CEA, primary malignancy was believed to be arising from the pancreas or from the gastrointestinal tract, though the definitive diagnosis of primary malignancy was not made. Although rare, metastatic mucinous adenocarcinoma should be kept in the differential diagnosis of CPA lesions. Even though the tumor is radiologically mimicking as CPA schwannoma, the absence of hearing abnormality should raise the suspicion for other diagnoses.
Introduction
Lesions such as lipoma, papilloma, glioma, or metastasis account for less than 1% of the cerebellopontine (CP) angle cistern tumors in adults. [1] Yuh et al. retrospectively reviewed 14 cases with magnetic resonance evidence of metastases to CP angle (CPA). The primary tumors were lung carcinoma (five patients), breast carcinoma (four patients), melanoma (two patients), prostatic carcinoma, squamous cell carcinoma of the nasopharynx, and non-Hodgkin lymphoma (one patient each). [2] Distant metastasis of mucinous adenocarcinoma from the gastrointestinal tract, ovaries, pancreas, lungs, breast, or urogenital system is a well-described entity. Mucinous adenocarcinomas from different primary sites are histologically identical with gland cells producing a copious amount of mucin. Ariai et al. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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in the CPA. The facial/vestibulocochlear nerve complex is an unusual location for metastatic disease in the central nervous system. The prognosis after metastatic mucinous adenocarcinoma to the cranial nerves in the CPA may be poor. [3] Serum carbohydrate antigen (CA) 19-9 is the most extensively validated pancreatic cancer biomarker with multiple clinical applications. CA 19-9 serum levels have a sensitivity and specificity of 79%-81% and 82%-90%, respectively, for the diagnosis of pancreatic cancer in symptomatic patients. A CA 19-9 serum level of <100 U/mL implies likely resectable disease, whereas levels >100 U/mL suggest unresectability or metastatic disease. [4] Carcinoembryonic antigen (CEA) is an oncofetal glycoprotein that is normally expressed by mucosal cells. Although CEA is most commonly associated with colorectal cancer, it can also be elevated in other malignancies such as breast, liver, stomach, and pancreas. CEA is used to detect relapse of colorectal cancer, and CA 19-9 may be helpful in establishing the nature of pancreatic masses. [5] The authors and cavitron ultrasonic surgical aspirator (Integra). The lesion was containing a thin layer of capsule which was partially separable from the surrounding cerebellum. The tumor was adhering to the petrous dura mater, which was separated, and the dura was coagulated with bipolar diathermy. A part of the tumor was seen entering into the IAM. Subtotal resection of the tumor was done [ Figure 3 ]. EVD was removed in the postoperative period. Postoperative examination showed a GCS score of 15/15, right lateral rectus palsy, and right cerebellar signs.
Histopathological report was metastasis from a mucinous adenocarcinoma. The patient was evaluated for the primary location of the malignancy. Chest X-ray, ultrasound of the thyroid, and thyroid function tests were normal. CA 19-9 was 949.37 U/mL (normal range: 0-30.9 U/mL) and serum CEA was 48.17 ng/mL (normal range: <3 ng/mL). CA-125 was 8.20 U/mL (normal <35 U/mL). Contrast-enhanced CT scan of the abdomen and pelvis was normal. esophagogastroduodenoscopy and colonoscopy were advised to look for the primary malignancy. The patient and relatives were not willing for the same. In view of raised CA 19-9 and CEA, primary malignancy was believed to be arising from the pancreas or from the gastrointestinal tract, though the definitive diagnosis of primary malignancy was not made. Adjuvant therapy with radiation was started in the oncology department. The patient died 2 months after the surgery secondary to respiratory tract infection and septicemia.
Microscopic examination
Section showed the fragments of atypical cells arranged in glandular pattern. Individual cells have abundant pale eosinophilic-to-clear vacuolated cytoplasm with pleomorphic nucleus with irregular chromatin distribution and some showing prominent nucleoli. Glandular lumen was filled with mucinous material. Microscopic examination was consistent with metastasis from mucinous adenocarcinoma [ Figure 4a and b].
Discussion
Metastatic tumors to the CPA encompass about 0.7% of all tumors in this region, making this diagnosis extremely rare. [6] Mucinous colorectal adenocarcinomas comprise approximately 1%-6% of all colorectal epithelial cancers. Frequently they are more advanced at diagnosis. They have a poorer prognosis than nonmucinous colorectal adenocarcinomas. [7] Il Joo et al. presented a rare case of a mucin-containing metastatic adenocarcinoma of the rectum mimicking cerebral hemorrhage. [8] Yuh et al. reviewed the clinical and MR findings of 14 patients with CPA metastasis. Useful clinical findings included acute onset and rapid progression of cranial nerve symptoms, especially seventh and/or eighth cranial nerve deficits (92.9%). MR findings showed 100% of patients report a rare case of metastatic mucinous adenocarcinoma with raised CA 19-9 and CEA presenting as CPA tumor.
Case Report
A 47-year-old female patient presented with a history of headache, vomiting, and diplopia for 2 months. Walking difficulty was noted for 1 month. There was no history suggestive of other systemic organ involvement. Examination revealed the Glasgow Coma Scale (GCS) score of 15/15, right lateral rectus palsy, and right cerebellar signs. Hearing was normal. There were no signs of facial nerve involvement.
Computed tomography (CT) scan showed a heterogeneous lesion occupying the right CPA and right cerebellar hemisphere [ Figure 1 ]. A 1.5-tesla contrast magnetic resonance imaging (MRI) brain showed a dural-based extra-axial 5 cm × 3.7 cm × 3.1 cm lesion in the right CPA and cerebellomedullary angle region involving the right cerebellar hemisphere, internal auditory meatus (IAM), and posterior surface of the right petrous bone. The lesion was T1 hypointense, T2 hyperintense, and heterogeneously enhancing on T1-contrast image [ Figure 2a -e]. Cystic space was noted. There was no diffusion restriction of the lesion. Brain stem was displaced to the left side. Differential diagnosis of CPA schwannoma, meningioma, or metastasis was made. During the course in the hospital, the patient's GCS deteriorated to E3V3M5 (E -eye, V -vocal, and M -motor). CT scan of the head showed the development of hydrocephalus. External ventricular drain (EVD) was inserted into the right lateral ventricle. The patient underwent surgery for posterior fossa tumor. Under general anesthesia with endotracheal intubation, the patient was positioned in the left three-quarter prone position. Right retromastoid retrosigmoid craniotomy was performed and the dura was opened. A grayish-red tumor occupying the right CPA and cerebellomedullary angle was noted. The tumor was soft in consistency and suckable with suction having multiple cranial nerve involvement and 85.7% bilateral. The cerebrospinal fluid dissemination and/or leptomeningeal extension may be an important pathway for metastatic spread to the CPA. Because the CPA metastasis may be the initial or only site of metastasis and may occur many years after the initial diagnosis of malignancy, MR findings with clinical correlation are not only useful for the detection of CPA metastases but also for their differentiation from the more common benign CPA tumors. [9] CA19-9 is the most commonly used and best-validated serum tumor marker for pancreatic cancer diagnosis in symptomatic patients and for monitoring therapy in patients with pancreatic adenocarcinoma. It exhibits a dramatic increase in its plasmatic levels during neoplastic disease. Several critical aspects for its clinical use, such as false-negative results in patients with Lewis (a-b-) genotype and false-positive elevation in patients with benign diseases, do not make it a good cancer-specific marker. In the last years, a large number of putative biomarkers for pancreatic cancer have been proposed, but none of these has shown to possess the requisite sensitivity/specificity to be introduced in clinical use. Therefore, although with important limitations we well know, CA 19-9 continues being the only pancreatic cancer marker actually in clinical use. [10] At the present time, the clinical applications of the CEA radioimmunoassay should be limited to the differential diagnosis of patients with suspicion of primary colorectal or pancreatic carcinoma, to the detection of distant metastasis in other types of carcinomas, and to the postoperative follow-up of patients who had elevated levels of CEA before surgery. [11] In the author's case, CPA tumor was histologically diagnosed as metastasis from mucinous adenocarcinoma. Radiological investigations did not identify any primary malignancy. However, in view of raised CA 19-9 and CEA levels along with normal CA 125, the most probable diagnosis of metastasis from pancreatic or gastrointestinal malignancy was made, even though it was not confirmed.
Conclusion
Although very rare, metastatic mucinous adenocarcinoma should be kept in the differential diagnosis of CPA lesions. Even though the tumor is radiologically mimicking as CPA schwannoma, the absence of hearing abnormality should raise the suspicion for other diagnosis.
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